How Can We Help You Achieve Drug Product Risk Control?

Annex 1 calls for contamination control strategies that address risk across the full manufacturing process, not just at the point of sterile filtration integrity testing. For single-use systems, this means evaluating potential vulnerabilities from initial design and component selection through validation, sterilization, handling, and use.

A lifecycle-based approach helps manufacturers identify potential failure modes, establish appropriate controls, and document the measures supporting process integrity. By applying quality-by-design principles and structured risk management, teams can reduce the likelihood of deviations while improving operational consistency and inspection readiness.

Watch this short video to explore practical ways to assess and mitigate contamination risks throughout the single-use system lifecycle and strengthen your strategy in response to evolving regulatory expectations.